Evolent Health, Inc. Restructuring and Related Cost, Cost Incurred to Date
Evolent Health, Inc. (EVH) had Restructuring and Related Cost, Cost Incurred to Date of $8.59 million as of 2021-12-31, per its 10-K filed 2023-02-24.
Discontinued › Notes › Restructuring and Related Cost, Expected Cost
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2023-02-24
- 2021-12-31: Restructuring and Related Cost, Cost Incurred to Date $8.59M.
- 2021-09-30: Restructuring and Related Cost, Cost Incurred to Date $7.32M.
- 2021-06-30: Restructuring and Related Cost, Cost Incurred to Date $7.32M.
- 2021-03-31: Restructuring and Related Cost, Cost Incurred to Date $6.66M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2021-12-31 | $8.59M 10-K · filed 2023-02-24 |
| 2021-09-30 | $7.32M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.32M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.66M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.27M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |